Literature DB >> 17723915

Mechanisms of drug-induced liver disease.

Basuki K Gunawan1, Neil Kaplowitz.   

Abstract

Drug-induced liver injury depends initially on development of hepatocyte stress and cell death, which can be induced directly by parent drugs or by toxic metabolites. Hepatocyte stress can lead to activation of built-in death programs for apoptosis or necrosis. Subsequently, the innate immune system's participation is recruited. The interplay between proinflammatory and anti-inflammatory components of innate immune system determines the outcome of drug-induced liver injury. Both environmental factors and genetic differences in cellular responses to stress and the innate immune response may account for different susceptibilities between individuals to drug-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723915     DOI: 10.1016/j.cld.2007.06.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  32 in total

Review 1.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

2.  Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine.

Authors:  Kevin R MacKenzie; Mingkun Zhao; Mercedes Barzi; Jin Wang; Karl-Dimiter Bissig; Mirjana Maletic-Savatic; Sung Yun Jung; Feng Li
Journal:  Eur J Pharm Sci       Date:  2020-07-23       Impact factor: 4.384

3.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

4.  High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2013-11-14       Impact factor: 1.738

5.  Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Authors:  Allen D Brinker; Jenna Lyndly; Joseph Tonning; David Moeny; Jonathan G Levine; Mark I Avigan
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

6.  Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

Authors:  Jiekun Xuan; Si Chen; Baitang Ning; William H Tolleson; Lei Guo
Journal:  Chem Biol Interact       Date:  2015-10-22       Impact factor: 5.192

Review 7.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

8.  Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-17       Impact factor: 4.030

9.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.

Authors:  Brittany V Martin-Murphy; Michael P Holt; Cynthia Ju
Journal:  Toxicol Lett       Date:  2009-12-01       Impact factor: 4.372

10.  Acetaminophen-induced acute liver injury in HCV transgenic mice.

Authors:  Takeki Uehara; Oksana Kosyk; Emmanuelle Jeannot; Blair U Bradford; Katherine Tech; Jeffrey M Macdonald; Gary A Boorman; Saurabh Chatterjee; Ronald P Mason; Stepan B Melnyk; Volodymyr P Tryndyak; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-29       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.